We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    CB-839 lung
Previous Study | Return to List | Next Study

Study CB-839 in Combination With Nivolumab in Patients With ccRCC and Other Solid Tumors

This study is currently recruiting participants.
Verified September 2017 by Calithera Biosciences, Inc
Sponsor:
ClinicalTrials.gov Identifier:
NCT02771626
First Posted: May 13, 2016
Last Update Posted: September 19, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Calithera Biosciences, Inc
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)